Biolarvicidal and pupicidal potential of silver nanoparticles synthesized using Euphorbia hirta against Anopheles stephensi Liston (Diptera: Culicidae)

被引:0
作者
Karthikeyan Agalya Priyadarshini
Kadarkarai Murugan
Chellasamy Panneerselvam
Sekar Ponarulselvam
Jiang-Shiou Hwang
Marcello Nicoletti
机构
[1] Bharathiar University,Division of Entomology, Department of Zoology, School of Life Sciences
[2] Bharathiar University,DRDO
[3] National Taiwan Ocean University,BU Center for Life Sciences
[4] Università La Sapienza,Institute of Marine Biology
来源
Parasitology Research | 2012年 / 111卷
关键词
Malaria; Silver Nanoparticles; Leaf Extract; Larvicidal Activity; Fourth Instar;
D O I
暂无
中图分类号
学科分类号
摘要
Vector control is a critical requirement in epidemic disease situations, as is an urgent need to develop new and improved mosquito control methods that are economical and effective yet safe for nontarget organisms and the environment. Mosquitoes transmit serious human diseases, causing millions of deaths every year. Use of synthetic insecticides to control vector mosquitoes has caused physiological resistance and adverse environmental effects in addition to high operational cost. Insecticides of synthesized natural products for vector control have been a priority in this area. In the present study, activity of silver nanoparticles (AgNPs) synthesized using Euphorbia hirta (E. hirta) plant leaf extract against malarial vector Anopheles stephensi (A. stephensi) was determined. Range of concentrations of synthesized AgNPs (3.125, 6.25, 12.5, 25, and 50 ppm) and methanol crude extract (50, 100, 150, 200, and 250 ppm) were tested against larvae of A. stephensi. The synthesized AgNPs from E. hirta were highly toxic than methanolic crude extract against malarial vector, A. stephensi. The synthesized AgNPs were characterized by UV-vis spectrum, scanning electron microscopy (SEM), and X-ray diffraction. SEM analyses of the synthesized showed that AgNPs, measuring 30–60 nm in size, were clearly distinguishable. The synthesized AgNPs showed larvicidal effects after 24 h of exposure; however, the highest larval mortality was found in the synthesized AgNPs against the first to fourth instar larvae and pupae of values LC50 (10.14, 16.82, 21.51, and 27.89 ppm, respectively), LC90 (31.98, 50.38, 60.09, and 69.94 ppm, respectively), and the LC50 and LC90 values of pupae of 34.52 and 79.76 ppm, respectively. Methanol extract exhibited the larval toxicity against the first to fourth instar larvae and pupae of values LC50 (121.51, 145.40, 169.11, and 197.40 ppm, respectively), LC90 (236.44, 293.75, 331.42, and 371.34 ppm, respectively), and the LC50 and LC90 values of pupae of 219.15 and 396.70 ppm, respectively. No mortality was observed in the control. These results suggest that synthesized silver nanoparticles are a rapid, eco-friendly, and single-step approach; the AgNPs formed can be potential mosquito larvicidal agents.
引用
收藏
页码:997 / 1006
页数:9
相关论文
共 252 条
  • [1] Abbott WS(1925)A method of computing the effectiveness of insecticides J Eco Ento 18 265-267
  • [2] Ahmad A(2003)Extracellular biosynthesis of silver nanoparticles using the fungus Colloids Surf B 28 313-318
  • [3] Mukherjee P(2009)Antifungal activity of silver nanoparticles against Candida spp Biomaterials 30 6333-6340
  • [4] Senapati S(2005)Biosynthesis of gold and silver nanoparticles using J Nanosci Nanotechnol 10 1665-1671
  • [5] Mandal D(2009) fruit extract, their phase transfer and transmetallation in an organic solution Colloides Surf B Biointerf 68 88-92
  • [6] Khan MI(2005)Extracellular biosynthesis of functionalized silver nanoparticles by strains of Agric Chem Biotechnol 43 185-191
  • [7] Kumar R(2006) fungus Biotechnol Prog 22 577-583
  • [8] Sastry M(1991)Insecticide targets: learning to keep up with resistance and changing concepts of safety China J Chin Mater Med 16 38-39
  • [9] AlesPana C(2010)Synthesis of gold nanotriangles and silver nanoparticles using Aloe vera plant extract J Pharm Sci Res 2 549-554
  • [10] Milan KR(2010)Studies on the polyphenols from leaves of Nanomed Nanotechnol Biol Med 6 103-109